Some mice were pretreated with anti-IFN-γ antibody (250 μg per day) once per two days for twice.
Arsenic treatment lead to a dramatic reduction in TSB levels, that was blocked when the mice were pretreated with NAC.
The mice were pretreated with liriodendrin (100 mg/kg/day, intragastrically) 3 days before DSS treatment.
In the prevention treatment, mice were pretreated with CDS, Li or saline prior to AMPH.
All mice were pretreated with scopolamine methylbromide (1 mg/kg) 30 min prior to pilocarpine administration.
GT-tg bigenic mice or C57BL/6J mice were pretreated daily with vehicle (0.9% saline, i.p). or Dox (100 mg/kg, i.p). for 7 days before locomotor testing.
Based on the immunoregulatory function of HQH extractum and the possible direct protective effect on injured kidneys, mice were pretreated with HQH before the injection of cisplatin.
mBSA-immunized C57BL/6 mice were pretreated with FBP (10, 30 or 100 mg.kg−1) or vehicle (Veh) 24 h and 30 min before challenge with mBSA (30 μg/knee joint).
In the in vivo study, male Kun-Ming mice were pretreated with single dose of GO (50 200 mg/kg body weight) at 2 h before ethanol (4.8 g/kg body weight) exposure.
In another set of experiments, mice were pretreated intraperitoneally with SCH-23390 (0.01 mg/kg) or Sulpiride (10 mg/kg) 30 min before saline or ethanol injection, for 21 days.
Yet when the mice were pretreated with naphthoquinone, dopamine levels fell only 40%.
